Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00605631 · ClinicalTrials.gov registry record · NA
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT00605631 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 105 participants.
The verdict
NCT00605631, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
This study is designed to evaluate the effect of pacing on post-MI patients.
Interventions
- DEVICE Cardiac pacing using any Guidant/Boston Scientific Implantable ICD or CRT-D System and any Guidant/Boston Scientific Intracardiac Lead System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2005-05 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00605631
The ClinicalTrials.gov registry entry for NCT00605631 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac pacing using any Guidant/Boston Scientific Implantable ICD or CRT-D System and any Guidant/Boston Scientific Intracardiac Lead System is the first listed.
NCT00605631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00605631 about?
NCT00605631 is a clinical study titled "The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study". This study is designed to evaluate the effect of pacing on post-MI patients.
What is the current status of trial NCT00605631?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2005-05. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00605631?
The interventions under investigation include: Cardiac pacing using any Guidant/Boston Scientific Implantable ICD or CRT-D System and any Guidant/Boston Scientific Intracardiac Lead System (DEVICE).
Who is sponsoring clinical trial NCT00605631?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.